Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $69.12 | 3 | 59.7% |
| Food and Beverage | $46.75 | 3 | 40.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $69.12 | 3 | $0 (2023) |
| GlaxoSmithKline, LLC. | $17.69 | 1 | $0 (2019) |
| Merck Sharp & Dohme LLC | $15.55 | 1 | $0 (2022) |
| Novo Nordisk Inc | $13.51 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $69.12 | 3 | PFIZER INC. ($69.12) |
| 2022 | $15.55 | 1 | Merck Sharp & Dohme LLC ($15.55) |
| 2019 | $17.69 | 1 | GlaxoSmithKline, LLC. ($17.69) |
| 2018 | $13.51 | 1 | Novo Nordisk Inc ($13.51) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/12/2023 | PFIZER INC. | MYFEMBREE (Drug) | Education | In-kind items and services | $23.04 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 03/10/2023 | PFIZER INC. | MYFEMBREE (Drug) | Education | In-kind items and services | $23.04 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 01/26/2023 | PFIZER INC. | MYFEMBREE (Drug) | Education | In-kind items and services | $23.04 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 02/14/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXNEUVANCE | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: VACCINE | ||||||
| 09/24/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: RESPIRATORY | ||||||
| 05/06/2018 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.51 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,286 | 1,513 | $227,227 | $66,895 |
| 2022 | 15 | 1,630 | 1,991 | $203,411 | $60,770 |
| 2021 | 16 | 815 | 1,132 | $217,030 | $62,512 |
| 2020 | 14 | 926 | 1,219 | $155,765 | $50,393 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 159 | 291 | $107,088 | $25,580 | 23.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 86 | 86 | $31,992 | $11,045 | 34.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 21 | 21 | $9,534 | $5,926 | 62.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 640 | 686 | $10,290 | $5,694 | 55.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 47 | 47 | $3,995 | $3,558 | 89.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 65 | $16,900 | $3,513 | 20.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 14 | $8,232 | $2,273 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $8,622 | $1,894 | 22.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 53 | 53 | $1,730 | $1,594 | 92.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $5,665 | $1,559 | 27.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 36 | 36 | $13,020 | $1,090 | 8.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 14 | 16 | $2,400 | $665.44 | 27.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 48 | 69 | $2,070 | $656.88 | 31.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 21 | 21 | $945.00 | $644.07 | 68.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 28 | 34 | $2,278 | $596.48 | 26.2% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 23 | 23 | $1,564 | $369.16 | 23.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 22 | $902.00 | $236.88 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 170 | 308 | $105,028 | $25,193 | 24.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 82 | 82 | $28,618 | $10,912 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 67 | 89 | $21,538 | $5,224 | 24.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 998 | 1,159 | $5,795 | $3,406 | 58.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 48 | 48 | $4,080 | $3,372 | 82.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 11 | 11 | $4,994 | $3,059 | 61.2% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 11 | 12 | $6,600 | $2,007 | 30.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 56 | 57 | $1,710 | $1,706 | 99.7% |
About Dr. Lauri Larson, MD
Dr. Lauri Larson, MD is a Family Medicine healthcare provider based in Walla Walla, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477567881.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lauri Larson, MD has received a total of $115.87 in payments from pharmaceutical and medical device companies, with $69.12 received in 2023. These payments were reported across 6 transactions from 4 companies. The most common payment nature is "Education" ($69.12).
As a Medicare-enrolled provider, Larson has provided services to 4,657 Medicare beneficiaries, totaling 5,855 services with total Medicare billing of $240,569. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Walla Walla, WA
- Active Since 07/28/2006
- Last Updated 06/16/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1477567881
Products in Payments
- MYFEMBREE (Drug) $69.12
- TRELEGY ELLIPTA (Drug) $17.69
- GARDASIL 9 (Biological) $15.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Walla Walla
George Waring, Md, MD
Family Medicine — Payments: $2,329
Dr. William Wagner, D.o, D.O
Family Medicine — Payments: $1,097
Jeffrey Pryor, D.o, D.O
Family Medicine — Payments: $860.98
Mr. Robert Morasch, M.d, M.D
Family Medicine — Payments: $809.51
Mark Haugen, M.d, M.D
Family Medicine — Payments: $766.09
Kevin Molander, M.d, M.D
Family Medicine — Payments: $395.78